Bahilid, Cristela P.
HRN: 23-82-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2023
CEFTRIAXONE 1G (VIAL)
09/30/2023
10/07/2023
IV
2gms
OD
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractBloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes